The ROE (Return on Equity) of Abcellera Biologics Inc (ABCL) is -15.42%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | -15.42% |
| 2023-12-31 | -12.70% |
| 2022-12-31 | 12.85% |
| 2021-12-31 | 14.97% |
| 2020-12-31 | 14.32% |
| 2019-12-31 | -21.36% |
| 2018-12-31 | 2.59% |